Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury

NCT06429007 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT06429007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain Injury
Lead sponsor
Boston Children's Hospital
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
October 1, 2025
Completion date
March 1, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hie, hypoxic-ischemic encephalopathy, infant development, neurodevelopment